EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Inhibitors of Carbonic Anhydrase I and II Identified by High Throughput Virtual Screening and Validated by X‐Ray Crystallography

Asher L Brandt, Joseph Venditto, Marta Ferraroni, Claudiu T Supuran iD, Andrea Angeli iD

ChemMedChem · 29.07.2026 · 21 (14)

DOI: 10.1002/cmdc.70391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 16.07.2026. Verfasst von Asher L Brandt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Saint Joseph, West Hartford, Connecticut, USA. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrase II, Carbonic Anhydrase I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐throughput virtual screening (HTVS) enables rapid exploration of large chemical spaces to identify novel modulators of biologically relevant targets. In this study, we applied a large‐scale docking campaign to discover new inhibitors of the human Carbonic Anhydrase isoforms I and II. Starting from library of 28,000 compounds, iterative Glide HTVS, SP, and XP docking against hCA I and hCA II yielded 81 top‐ranked compounds for experimental evaluation. Among these, five compounds showed micromolar inhibition of hCA II, and one also inhibited hCA I. X‐ray crystallographic studies of two carboxylate‐based inhibitors ( 1 and 2 ) revealed distinct binding modes. Compound 1 directly coordinates the catalytic zinc ion, whereas compound 2 adopts two different binding poses: one anchored to the zinc‐bound water molecule and another within a surface‐accessible pocket near His64. The latter region, which modulates the proton‐shuttling mechanism essential for catalysis, represents a less‐explored site for inhibitor development. Overall, these findings validate our HTVS workflow and provide a foundation for the structure‐guided optimization of carboxylate scaffolds as carbonic anhydrase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsCarbonic Anhydrase IICarbonic Anhydrase ICrystallography, X-RayHumansHigh-Throughput Screening AssaysStructure-Activity RelationshipMolecular Docking SimulationMolecular Structure

Stichwörter der Autor:innen

X‐ray crystallographycarbonic anhydrasecarboxylic acidshigh throughput virtual screeningmetalloenzyme

Substanzen

Carbonic Anhydrase InhibitorsCarbonic Anhydrase IICarbonic Anhydrase I

Autor:innen und Institutionen

  • Department of Chemistry, University of Saint Joseph, West Hartford, Connecticut, USA.
  • Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy.
  • NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Florence, Italy.

ORCID-Profile: Claudiu T Supuran, Andrea Angeli

Zitieren

APA

Brandt, A. L., Venditto, J., Ferraroni, M., Supuran, C. T., & Angeli, A. (2026). Novel Inhibitors of Carbonic Anhydrase I and II Identified by High Throughput Virtual Screening and Validated by X‐Ray Crystallography. ChemMedChem, 21(14). https://doi.org/10.1002/cmdc.70391

Vancouver

Brandt AL, Venditto J, Ferraroni M, Supuran CT, Angeli A. Novel Inhibitors of Carbonic Anhydrase I and II Identified by High Throughput Virtual Screening and Validated by X‐Ray Crystallography. ChemMedChem. 2026;21(14). doi:10.1002/cmdc.70391

BibTeX
@article{Brandt2026,
  author = {Brandt, Asher L and Venditto, Joseph and Ferraroni, Marta and Supuran, Claudiu T and Angeli, Andrea},
  title = {Novel Inhibitors of Carbonic Anhydrase I and II Identified by High Throughput Virtual Screening and Validated by X‐Ray Crystallography},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {14},
  doi = {10.1002/cmdc.70391}
}
Kostenlos starten →